{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:42:48Z","timestamp":1792795368408,"version":"4.5.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de recherche du Qu\u00e9bec Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007185","name":"University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Imaging"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jcmg.2025.03.011","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T14:09:06Z","timestamp":1748441346000},"page":"815-833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Established and Emerging Fluorine-18\u2013Labeled Cardiac PET Radiotracers"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8520-5843","authenticated-orcid":false,"given":"Ren\u00e9 R. Sevag","family":"Packard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Pelletier-Galarneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9396-9579","authenticated-orcid":false,"given":"Saurabh","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1462-1185","authenticated-orcid":false,"given":"Sharmila","family":"Dorbala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wengen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasken","family":"Dilsizian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmg.2025.03.011_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/bc500475e","article-title":"Fluorine-18 radiochemistry, labeling strategies and synthetic routes","volume":"26","author":"Jacobson","year":"2015","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.jcmg.2025.03.011_bib2","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1038\/s41467-023-36377-4","article-title":"Radiochemistry for positron emission tomography","volume":"14","author":"Rong","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmg.2025.03.011_bib3","first-page":"55","article-title":"Positron emission tomography (PET) imaging with (18)F-based radiotracers","volume":"2","author":"Alauddin","year":"2012","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.jcmg.2025.03.011_bib5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jcmg.2024.01.004","volume":"17","author":"Bourque","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib6","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12350-016-0522-3","article-title":"ASNC imaging guidelines\/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures","volume":"23","author":"Dilsizian","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib7","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s12350-021-02681-z","article-title":"The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis: a systematic review","volume":"28","author":"Ahmed","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib9","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.jcmg.2020.11.016","article-title":"Pre-treatment myocardial 18FDG uptake predicts response to immunosuppression in patients with cardiac sarcoidosis","volume":"14","author":"Subramanian","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib10","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s00259-018-4001-8","article-title":"Prognostic role of serial quantitative evaluation of (18)F-fluorodeoxyglucose uptake by PET\/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia","volume":"45","author":"Muser","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in (1)(8)F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib12","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1056\/NEJM198604033141405","article-title":"Reversibility of cardiac wall-motion abnormalities predicted by positron tomography","volume":"314","author":"Tillisch","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcmg.2025.03.011_bib13","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.2967\/jnumed.108.053892","article-title":"18F-FDG uptake as a surrogate marker for antecedent ischemia","volume":"49","author":"Dilsizian","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jcmg.2025.03.011_bib14","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jcmg.2018.08.026","article-title":"Merits of FDG PET\/CT and functional molecular imaging over anatomic imaging with echocardiography and CT angiography for the diagnosis of cardiac device infections","volume":"11","author":"Chen","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib15","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.jacc.2013.01.092","article-title":"Positron emission tomography\/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion","volume":"61","author":"Saby","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib16","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.115.015316","article-title":"Improving the diagnosis of infective endocarditis in prosthetic valves and intracardiac devices with 18F-fluordeoxyglucose positron emission tomography\/computed tomography angiography: initial results at an infective endocarditis referral center","volume":"132","author":"Pizzi","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2025.03.011_bib17","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","article-title":"2023 ESC guidelines for the management of endocarditis","volume":"44","author":"Delgado","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2025.03.011_bib18","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"77","author":"Otto","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib19","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/S1473-3099(16)30141-4","article-title":"Diagnostic value of imaging in infective endocarditis: a systematic review","volume":"17","author":"Gomes","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.jcmg.2025.03.011_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005772","article-title":"Positron emission tomography and single-photon emission computed tomography imaging in the diagnosis of cardiac implantable electronic device infection: a systematic review and meta-analysis","volume":"10","author":"Juneau","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib21","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1469-0691.2010.03312.x","article-title":"Whole body [(18) F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: a preliminary prospective study","volume":"17","author":"Bensimhon","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jcmg.2025.03.011_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007188","article-title":"Diagnostic impact of (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography and white blood cell SPECT\/computed tomography in patients with suspected cardiac implantable electronic device chronic infection","volume":"12","author":"Calais","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.120.010600","article-title":"Diagnosis of infective endocarditis by subtype using (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography: a contemporary meta-analysis","volume":"13","author":"Wang","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib24","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jcmg.2018.01.024","article-title":"FDG PET\/CT for early detection and localization of left ventricular assist device infection: impact on patient management and outcome","volume":"12","author":"Kim","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib25","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jcmg.2021.09.029","article-title":"Best practices for imaging cardiac device-related infections and endocarditis: a JACC: Cardiovascular Imaging Expert Panel Statement","volume":"15","author":"Dilsizian","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib26","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.jcmg.2019.04.024","article-title":"Diagnostic accuracy of FDG PET\/CT in suspected LVAD infections: a case series, systematic review, and meta-analysis","volume":"13","author":"Tam","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014652","article-title":"Molecular imaging of valvular diseases and cardiac device infection","volume":"16","author":"Tarkin","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s44161-024-00587-w","article-title":"The clinical promise of (18)F-flurpiridaz PET imaging heralds a new frontier in the diagnosis and management of coronary artery disease","volume":"4","author":"Packard","year":"2025","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.jcmg.2025.03.011_bib29","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.nuclcard.2007.07.009","article-title":"Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: a novel PET myocardial imaging agent","volume":"14","author":"Yalamanchili","year":"2007","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib30","doi-asserted-by":"crossref","first-page":"630","DOI":"10.2967\/jnumed.107.044727","article-title":"Initial characterization of an 18F-labeled myocardial perfusion tracer","volume":"49","author":"Huisman","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jcmg.2025.03.011_bib31","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1161\/CIRCULATIONAHA.108.797761","article-title":"Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model","volume":"119","author":"Nekolla","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2025.03.011_bib32","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.nuclcard.2007.07.008","article-title":"BMS-747158-02: a novel PET myocardial perfusion imaging agent","volume":"14","author":"Yu","year":"2007","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib33","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.2967\/jnumed.111.092528","article-title":"Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest","volume":"52","author":"Maddahi","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jcmg.2025.03.011_bib34","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1007\/s12350-018-01484-z","article-title":"Dosimetry, biodistribution, and safety of flurpiridaz F 18 in healthy subjects undergoing rest and exercise or pharmacological stress PET myocardial perfusion imaging","volume":"26","author":"Maddahi","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jacc.2020.05.063","article-title":"Phase-III clinical trial of fluorine-18 flurpiridaz positron emission tomography for evaluation of coronary artery disease","volume":"76","author":"Maddahi","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib36","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2967\/jnumed.120.252007","article-title":"Diagnostic performance of PET versus SPECT myocardial perfusion imaging in patients with smaller left ventricles: a substudy of the (18)F-flurpiridaz phase III clinical trial","volume":"62","author":"Packard","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jcmg.2025.03.011_bib37","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacc.2023.08.016","article-title":"Flurpiridaz F-18 PET myocardial perfusion imaging in patients with suspected coronary artery disease","volume":"82","author":"Maddahi","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib38","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.2967\/jnumed.114.141093","article-title":"Absolute quantitation of myocardial blood flow in human subjects with or without myocardial ischemia using dynamic flurpiridaz F 18 PET","volume":"55","author":"Packard","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jcmg.2025.03.011_bib39","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1093\/ehjci\/jeab267","article-title":"18F-flurpiridaz positron emission tomography segmental and territory myocardial blood flow metrics: incremental value beyond perfusion for coronary artery disease categorization","volume":"23","author":"Packard","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib40","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s12350-020-02335-6","article-title":"Development, diagnostic performance, and interobserver agreement of a (18)F-flurpiridaz PET automated perfusion quantitation system","volume":"29","author":"Packard","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib41","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00259-021-05643-2","article-title":"Improved myocardial blood flow estimation with residual activity correction and motion correction in (18)F-flurpiridaz PET myocardial perfusion imaging","volume":"49","author":"Otaki","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib42","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s12350-020-02034-2","article-title":"Added value of myocardial blood flow using (18)F-flurpiridaz PET to diagnose coronary artery disease: the flurpiridaz 301 trial","volume":"28","author":"Moody","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib43","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/ehjci\/jey187","article-title":"Referral of patients for fractional flow reserve using quantitative flow ratio","volume":"20","author":"Smit","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib44","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/ehjci\/jew148","article-title":"Fractional flow reserve by computerized tomography and subsequent coronary revascularization","volume":"18","author":"Packard","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/ehjci\/jead229","article-title":"Distal-vessel fractional flow reserve by computed tomography to monitor epicardial coronary artery disease","volume":"25","author":"Chen","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib46","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jacc.2020.12.019","article-title":"Absolute coronary blood flow measured by continuous thermodilution in patients with ischemia and nonobstructive disease","volume":"77","author":"Konst","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib47","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202401200R","article-title":"Electrochemical impedance spectroscopy unmasks high-risk atherosclerotic features in human coronary artery disease","volume":"38","author":"Chen","year":"2024","journal-title":"FASEB J"},{"key":"10.1016\/j.jcmg.2025.03.011_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.101823","article-title":"Phase I, first-in-human study of XTR004, a novel (18)F-labeled tracer for myocardial perfusion PET: biodistribution, radiation dosimetry, pharmacokinetics, and safety after a single injection at rest","volume":"34","author":"Ren","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.101834","article-title":"Expanding the repertoire of (18)F-labeled PET MPI radiotracers","volume":"34","author":"Packard","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib50","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1007\/s00259-024-07004-1","article-title":"Comparative evaluation of a novel [(18)F] F-labeled PET tracer XTR004 against [(13)N] ammonia in myocardial perfusion imaging for coronary artery disease","volume":"52","author":"Wang","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib51","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13550-024-01122-5","article-title":"Preclinical evaluation of [(18)F]SYN1 and [(18)F]SYN2, novel radiotracers for PET myocardial perfusion imaging","volume":"14","author":"Krajewski","year":"2024","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.jcmg.2025.03.011_bib52","doi-asserted-by":"crossref","first-page":"14678","DOI":"10.1073\/pnas.0606310103","article-title":"A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps","volume":"103","author":"Vengrenyuk","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmg.2025.03.011_bib53","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.2967\/jnumed.110.077933","article-title":"Molecular mechanisms of bone 18F-NaF deposition","volume":"51","author":"Czernin","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jcmg.2025.03.011_bib54","doi-asserted-by":"crossref","first-page":"7495","DOI":"10.1038\/ncomms8495","article-title":"Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography","volume":"6","author":"Irkle","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmg.2025.03.011_bib55","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.120.011438","article-title":"Coronary (18)F-fluoride uptake and progression of coronary artery calcification","volume":"13","author":"Doris","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib56","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jacc.2011.12.037","article-title":"Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology","volume":"59","author":"Dweck","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib57","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00259-016-3552-9","article-title":"Thoracic aorta calcification but not inflammation is associated with increased cardiovascular disease risk: results of the CAMONA study","volume":"44","author":"Blomberg","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib58","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.atherosclerosis.2020.12.010","article-title":"Coronary (18)F-sodium fluoride PET detects high-risk plaque features on optical coherence tomography and CT-angiography in patients with acute coronary syndrome","volume":"319","author":"Majeed","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jcmg.2025.03.011_bib59","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s12350-020-02284-0","article-title":"(18)F-NaF PET uptake characteristics of coronary artery culprit lesions in a cohort of patients of acute coronary syndrome with ST-elevation myocardial infarction and chronic stable angina: a hybrid fluoride PET\/CTCA study","volume":"29","author":"Ashwathanarayana","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib60","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(13)61754-7","article-title":"18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial","volume":"383","author":"Joshi","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jcmg.2025.03.011_bib61","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.jacc.2020.04.046","article-title":"Coronary (18)F-sodium fluoride uptake predicts outcomes in patients with coronary artery disease","volume":"75","author":"Kwiecinski","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib62","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/cells10020275","article-title":"Sodium [(18)F]fluoride PET can efficiently monitor in vivo atherosclerotic plaque calcification progression and treatment","volume":"10","author":"Florea","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jcmg.2025.03.011_bib63","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s12350-019-02004-3","article-title":"Changes in microarchitecture of atherosclerotic calcification assessed by (18)F-NaF PET and CT after a progressive exercise regimen in hyperlipidemic mice","volume":"28","author":"Hsu","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib64","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1161\/CIRCRESAHA.110.234146","article-title":"Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification","volume":"108","author":"New","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.jcmg.2025.03.011_bib65","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jamacardio.2023.1729","article-title":"Coronary atherosclerotic plaque activity and future coronary events","volume":"8","author":"Moss","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib66","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jcmg.2019.07.015","article-title":"How to image cardiac amyloidosis: a practical approach","volume":"13","author":"Dorbala","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib67","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","article-title":"Imaging cardiac amyloidosis: a pilot study using (1)(8)F-florbetapir positron emission tomography","volume":"41","author":"Dorbala","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib68","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/13506129.2018.1467313","article-title":"Utility of the (18)F-florbetapir positron emission tomography in systemic amyloidosis","volume":"25","author":"Mestre-Torres","year":"2018","journal-title":"Amyloid"},{"key":"10.1016\/j.jcmg.2025.03.011_bib69","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s12149-019-01372-7","article-title":"Amyloid PET imaging in cardiac amyloidosis: a pilot study using (18)F-flutemetamol positron emission tomography","volume":"33","author":"Dietemann","year":"2019","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.jcmg.2025.03.011_bib70","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/13506129.2020.1760237","article-title":"Quantification of cardiac amyloid with [(18)F]Flutemetamol in patients with V30M hereditary transthyretin amyloidosis","volume":"27","author":"Mockelind","year":"2020","journal-title":"Amyloid"},{"key":"10.1016\/j.jcmg.2025.03.011_bib71","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s12350-020-02363-2","article-title":"(18)F-flutemetamol positron emission tomography in cardiac amyloidosis","volume":"29","author":"Papathanasiou","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib72","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2967\/jnumed.115.169870","article-title":"Cardiac amyloid imaging with 18F-florbetaben PET: a pilot study","volume":"57","author":"Law","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jcmg.2025.03.011_bib73","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00259-019-04290-y","article-title":"Detection of cardiac amyloidosis with (18)F-florbetaben-PET\/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy","volume":"46","author":"Kircher","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib74","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcmg.2020.05.031","article-title":"[18F]-florbetaben PET\/CT for differential diagnosis among cardiac immunoglobulin light chain, transthyretin amyloidosis, and mimicking conditions","volume":"14","author":"Genovesi","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib75","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12350-018-01552-4","article-title":"State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis","volume":"26","author":"Singh","year":"2019","journal-title":"J Nucl Cardiol"},{"issue":"8","key":"10.1016\/j.jcmg.2025.03.011_bib76","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.114.002954","article-title":"18F-florbetapir binds specifically to myocardial light chain and transthyretin amyloid deposits: autoradiography study","volume":"8","author":"Park","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib77","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/13506129.2022.2141623","article-title":"The flutemetamol analogue cyano-flutemetamol detects myocardial AL and ATTR amyloid deposits: a post-mortem histofluorescence analysis","volume":"30","author":"Abrahamson","year":"2023","journal-title":"Amyloid"},{"key":"10.1016\/j.jcmg.2025.03.011_bib78","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1021\/jacs.1c12056","article-title":"Binding sites of a positron emission tomography imaging agent in Alzheimer's beta-amyloid fibrils studied using (19)F solid-state NMR","volume":"144","author":"Duan","year":"2022","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.jcmg.2025.03.011_bib79","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.jacc.2016.09.953","article-title":"(18)F-sodium fluoride PET\/MR for the assessment of cardiac amyloidosis","volume":"68","author":"Trivieri","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib80","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12350-019-01675-2","article-title":"Examining the sensitivity of 18F-NaF PET for the imaging of cardiac amyloidosis","volume":"28","author":"Martineau","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib81","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2967\/jnumed.111.102053","article-title":"In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET","volume":"54","author":"Antoni","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jcmg.2025.03.011_bib82","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jcmg.2023.07.007","article-title":"Cardiac amyloid quantification using (124)I-evuzamitide ((124)I-P5+14) versus (18)F-florbetapir: a pilot PET\/CT study","volume":"16","author":"Clerc","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib83","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jcmg.2023.08.009","article-title":"Cardiac amyloid detection by PET\/CT imaging of iodine ((124)I) evuzamitide ((124)I-p5+14): a phase 1\/2 study","volume":"16","author":"Wall","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib84","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.2967\/jnumed.122.264866","article-title":"Molecular imaging of systemic and cardiac amyloidosis: recent advances and focus on the future","volume":"64","author":"Dorbala","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jcmg.2025.03.011_bib85","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jcmg.2023.09.002","article-title":"Shining a radiant light on cardiac amyloidosis with novel (124)I-evuzamitide PET imaging","volume":"16","author":"Pelletier-Galarneau","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib86","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jcmg.2019.10.015","article-title":"Low sensitivity of bone scintigraphy in detecting Phe64Leu mutation-related transthyretin cardiac amyloidosis","volume":"13","author":"Musumeci","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib87","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jcmg.2020.02.025","article-title":"Improved quantification of cardiac amyloid burden in systemic light chain amyloidosis: redefining early disease?","volume":"13","author":"Cuddy","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.jcmg.2025.03.011_bib88","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jcmg.2024.05.002","article-title":"Prognostic value of left ventricular (18)F-florbetapir uptake in systemic light-chain amyloidosis","volume":"17","author":"Clerc","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.jcmg.2025.03.011_bib89","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/ehjci\/jeae332","article-title":"Estimated total amyloid burden from 18F-florbetaben PET predicts all-cause mortality in light-chain cardiac amyloidosis","volume":"26","author":"Vergaro","year":"2025","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib90","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1016\/j.ejca.2012.05.001","article-title":"Correlation between Ki-67 immunohistochemistry and 18F-fluorothymidine uptake in patients with cancer: a systematic review and meta-analysis","volume":"48","author":"Chalkidou","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jcmg.2025.03.011_bib91","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13550-017-0321-0","article-title":"Comparative evaluation of (18)F-FLT and (18)F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis","volume":"7","author":"Norikane","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.jcmg.2025.03.011_bib92","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.jcmg.2019.06.020","article-title":"Imaging cardiac sarcoidosis with FLT-PET compared with FDG\/Perfusion-PET: a prospective pilot study","volume":"12","author":"Martineau","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib93","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13550-020-00742-x","article-title":"FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: a prospective study with comparison to FDG-PET","volume":"10","author":"Martineau","year":"2020","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.jcmg.2025.03.011_bib94","first-page":"63","article-title":"Incidental detection and monitoring of spontaneous recovery of sarcoidosis via fluorine-18-fluoroethyl-choline positron emission tomography\/computed tomography","volume":"15","author":"Takesh","year":"2012","journal-title":"Hell J Nucl Med"},{"key":"10.1016\/j.jcmg.2025.03.011_bib95","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/RLU.0000000000000303","article-title":"(18)F-choline PET\/CT pitfalls in image interpretation: an update on 300 examined patients with prostate cancer","volume":"39","author":"Calabria","year":"2014","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jcmg.2025.03.011_bib96","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/01.RES.67.1.240","article-title":"Fluoromisonidazole: a metabolic marker of myocyte hypoxia","volume":"67","author":"Martin","year":"1990","journal-title":"Circ Res"},{"key":"10.1016\/j.jcmg.2025.03.011_bib97","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s12350-019-01976-6","article-title":"(18)F-FMISO PET\/CT detects hypoxic lesions of cardiac and extra-cardiac involvement in patients with sarcoidosis","volume":"28","author":"Furuya","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib98","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jacc.2013.07.096","article-title":"Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy","volume":"63","author":"Fallavollita","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib99","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.jcmg.2022.01.014","article-title":"Myocardial denervation and left ventricular volume predict ventricular arrhythmias in patients with ischemic cardiomyopathy","volume":"15","author":"Malhotra","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib100","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/CIRCIMAGING.110.962126","article-title":"Evaluation of LMI1195, a novel 18F-labeled cardiac neuronal PET imaging agent, in cells and animal models","volume":"4","author":"Yu","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib101","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2967\/jnumed.114.140137","article-title":"Biodistribution and radiation dosimetry of LMI1195: first-in-human study of a novel 18F-labeled tracer for imaging myocardial innervation","volume":"55","author":"Sinusas","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jcmg.2025.03.011_bib102","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jcmg.2020.09.026","article-title":"Regional distribution of fluorine-18-flubrobenguane and carbon-11-hydroxyephedrine for cardiac PET imaging of sympathetic innervation","volume":"14","author":"Zelt","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib103","article-title":"First-in-human studies of [(18)F] fluorohydroxyphenethylguanidines","volume":"11","author":"Raffel","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib104","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jcmg.2019.05.034","article-title":"Structural and physiological imaging to predict the risk of lethal ventricular arrhythmias and sudden death","volume":"12","author":"Malhotra","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib105","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.jcmg.2022.10.001","article-title":"Molecular imaging: new promises","volume":"15","author":"Dilsizian","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib106","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1007\/s00259-021-05470-5","article-title":"Clinical translational evaluation of Al(18)F-NOTA-FAPI for fibroblast activation protein-targeted tumour imaging","volume":"48","author":"Wang","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib107","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221052","article-title":"Myocardial activity at (18)F-FAPI PET\/CT and risk for sudden cardiac death in hypertrophic cardiomyopathy","volume":"306","author":"Wang","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.jcmg.2025.03.011_bib108","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2025.03.011_bib109","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11886-021-01500-8","article-title":"Quantification of myocardial mitochondrial membrane potential using PET","volume":"23","author":"Pelletier-Galarneau","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jcmg.2025.03.011_bib110","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3389\/fphys.2020.00491","article-title":"In-vivo imaging of mitochondrial depolarization of myocardium with positron emission tomography and a proton gradient uncoupler","volume":"11","author":"Alpert","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.jcmg.2025.03.011_bib111","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.1038\/s41586-020-2366-x","article-title":"In vivo quantification of mitochondrial membrane potential","volume":"583","author":"Alpert","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jcmg.2025.03.011_bib112","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1038\/s41598-022-10004-6","article-title":"PET imaging of mitochondrial function in acute doxorubicin-induced cardiotoxicity: a proof-of-principle study","volume":"12","author":"Detmer","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmg.2025.03.011_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190968","article-title":"Quantitative in vivo mapping of myocardial mitochondrial membrane potential","volume":"13","author":"Alpert","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmg.2025.03.011_bib114","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00259-020-04878-9","article-title":"In vivo quantitative mapping of human mitochondrial cardiac membrane potential: a feasibility study","volume":"48","author":"Pelletier-Galarneau","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib115","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1093\/eurheartj\/ehac716","article-title":"Economic, ethical, and environmental sustainability of cardiac imaging","volume":"44","author":"Picano","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2025.03.011_bib116","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1080\/13696998.2024.2431413","article-title":"A US payer budget impact analysis of Flurpiridaz-PET-MPI compared to SPECT-MPI in the diagnosis of coronary artery disease","volume":"27","author":"Priest","year":"2024","journal-title":"J Med Econ"},{"key":"10.1016\/j.jcmg.2025.03.011_bib117","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jcmg.2022.10.022","article-title":"National trends in coronary artery disease imaging: associations with health care outcomes and costs","volume":"16","author":"Weir-McCall","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2025.03.011_bib118","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2967\/jnumed.106.038323","article-title":"Impact of myocardial perfusion imaging with PET and (82)Rb on downstream invasive procedure utilization, costs, and outcomes in coronary disease management","volume":"48","author":"Merhige","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jcmg.2025.03.011_bib119","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00259-007-0647-3","article-title":"(13)N-ammonia myocardial perfusion imaging with a PET\/CT scanner: impact on clinical decision making and cost-effectiveness","volume":"35","author":"Siegrist","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["JACC: Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X25001731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X25001731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T01:09:59Z","timestamp":1782954599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936878X25001731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":119,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1936878X25001731"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmg.2025.03.011","relation":{},"ISSN":["1936-878X"],"issn-type":[{"value":"1936-878X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Established and Emerging Fluorine-18\u2013Labeled Cardiac PET Radiotracers","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmg.2025.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}